Related Experiment Video
Updated: Apr 30, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Support our campaign for better treatment for people with MS
1MS Society.
Abstract:
Two new medicines for people with multiple sclerosis (MS) have recently been approved for use on the NHS, and two more will hopefully follow within the next year, taking the total to 11. It is an exciting, unprecedented time, but people with MS continue to face significant difficulties accessing the treatments they need, the information to decide what is right for them, and the MS specialists who can help.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Alzheimer's Disease: Treatment
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

